Difference between revisions of "WSI21-131-Case-3"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 30: Line 30:
 
|subject=Z0FBQUFBQmhEQldKODJROG96N2NSQzNCOGNwRzNtV1l5aUxJbFhhX2lHTWRGN0c3ZXlQcGt3Sm0yODlSN1RGOUNYYzNpRkxzTEl2OENNMVZZLVY4R3RzUGVndmxSa0w2NVE9PQ
 
|subject=Z0FBQUFBQmhEQldKODJROG96N2NSQzNCOGNwRzNtV1l5aUxJbFhhX2lHTWRGN0c3ZXlQcGt3Sm0yODlSN1RGOUNYYzNpRkxzTEl2OENNMVZZLVY4R3RzUGVndmxSa0w2NVE9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mlz8
 +
|authoredOn=August 05, 2021 04:43:52 PM
 
}}
 
}}

Latest revision as of 14:08, December 9, 2024

WSI21-131-Case-3
59yo female with multiple myeloma s/p chemotherapy and BMT, annual pap smear
Atypical squamous cells, favor reactive changes due to chemotherapy (SP: Benign)
December 31, 1969 7:00:00 PM